Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06732596 · ClinicalTrials.gov registry record · NA

Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents

A NA study of Opioid Use Disorder, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT06732596 is a NA study of Opioid Use Disorder that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 100 participants, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06732596, a NA study of Opioid Use Disorder, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simulate natural face-to-face conversations. ECAs have been shown to help individuals manage their healthcare in other settings, and this study seeks to evaluate their potential in supporting patients on medication for opioid use disorder (MOUD).

Conditions Studied

Opioid Use Disorder

Interventions

  • OTHER Embodied conversational agent (ECA)
  • OTHER Technical support
  • OTHER Additional ECA messages
  • OTHER Additional incentives

Study Locations (1)

Massachusetts

  • Office-Based Addiction Treatment (OBAT) Clinic, BMC - Boston

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-30
Est. Completion 2026-12
Phase NA

Sponsor

Boston Medical Center

253 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06732596

The ClinicalTrials.gov registry entry for NCT06732596 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,656-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (98% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Opioid Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Embodied conversational agent (ECA) is the first listed.

NCT06732596 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06732596 about?

NCT06732596 is a clinical study titled "Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents". This study aims to improve retention in buprenorphine treatment, a medication used for opioid use disorder, through the use of a smartphone-delivered recovery support intervention. The intervention involves an Embodied Conversational Agent (ECA), a virtual, animated computer agent designed to simula...

What is the current status of trial NCT06732596?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-30. Estimated completion is 2026-12.

What conditions does trial NCT06732596 study?

This clinical trial studies the following conditions: Opioid Use Disorder.

What interventions are being tested in trial NCT06732596?

The interventions under investigation include: Embodied conversational agent (ECA) (OTHER), Technical support (OTHER), Additional ECA messages (OTHER), Additional incentives (OTHER).

Who is sponsoring clinical trial NCT06732596?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06732596 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.